The NovaCath secure IV catheter system is a pre-assembled, closed system that integrates the catheter, high pressure extension tubing, multi-use flow control clamp and stabilization technology, according to the company.
“Up to 50 percent of all short-peripheral IV catheters develop complications that negatively impact catheter dwell times, clinical outcomes, patient safety and patient satisfaction,” said Curtis Bloch, vice president of sales and marketing for Tangent Medical, in the release. “Our innovative, closed IV catheter design uniquely integrates advanced catheter stabilization, next generation tubing management, passive needle encapsulation and blood control on every short-peripheral IV start. Our research with clinicians has validated there is nothing like it in the market. FDA clearance will pave the way for us to advance the safety and efficacy of IV therapy.”
Tangent Medical recently unveiled the NovaCath system at the Infusion Nurses Society conference in Las Vegas.
Tangent Medical is headquartered in Ann Arbor, Mich.
Related Articles on FDA Clearances:
Iconacy Orthopedic Implants Receives FDA Clearance for Total Hip Replacement System
Covidien Receives FDA Clearance of Small Jaw Instrument for ENT Surgical Procedures
Precision Spine Receives FDA Clearance for Anterior Cervical Plate System
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.